Salaries posted anonymously by abraxis bioscience employees. There are 18 companies that go by the name of abraxis bioscience, llc. Abraxis has created, developed, and commercialized the first oncology product for the treatment of metastatic breast cancer using abraxis proprietary nanoparticle technology. Pr newswires news distribution, targeting, monitoring and marketing solutions help you connect and engage with target audiences across the globe. In addition, investors and stockholders may obtain free copies of the documents filed with the sec by directing a written request to. Celgene corporation, incorporated in delaware and headquartered in summit, new jersey. The following table lists the ndc drug codes by abraxis bioscience, llc.
Abraxis opens flagship nanotech manufacturing plant in. Cornell avenue, melrose park, illinois incorporated by reference to exhibit 10. Abbi stock, price quote and chart, trading and investing tools. The present invention provides methods of delivering a composition comprising nanoparticles that comprise a macrolide and an albumin by directly injecting the nanoparticle composition into the blood vessel wall or the tissue surrounding the blood vessel wall. Celgene corporation, 86 morris avenue, summit, new jersey. Phoenix, az 85043 310 8830 visit website get directions detailed information. Abraxis bioscience, llc is a north carolina limitedliability company filed on december 7, 2007. Mar 15, 2007 filing 179 opinion filed re 7 motion for joinder pursuant to federal rule 25 filed by abraxis bioscience, inc. A free inside look at abraxis bioscience salary trends based on 36 salaries wages for 23 jobs at abraxis bioscience. Celgene to acquire receptos, advancing leadership in immune.
Justia patents patents and patent application resources. From this the company developed abraxane, a treatment for metastatic breast cancer. Cjeu judgment c44317 abraxis bioscience 21 mar 2019. The companys filing status is listed as withdrawn by merger and its file number is 0871098. Supplementary protection certificate for medicinal products applicant abraxis bioscience llc issue whether spc application gb09046 complies with article 3d, having regard to article 1b, of the regulation hearing officer dr jim houlihan. In 2010, celgene bought soonshiongs abraxis bioscience inc. Abraxis pharmaceutical products will become app inc. Abraxis bioscience llc v comptroller general of patents. From the discovery and research phase to development and commercialization, abraxis bioscience is. Explore the therapies for hematology, oncology, inflammation and immunology and the medical research to help people live longer, better, and healthier. Abraxis that may occur or be announced after this press release. You have to know whats happening with clients, competitors, practice areas, and industries. The present invention provides prionfree compositions comprising nanoparticles comprising albumin and substantially water insoluble drugs. Summit biosciences is a specialized pharmaceutical company that develops, manufactures and commercializes prescription nasal spray products.
Cancer researcherturnedbillionaire starts new company. The registered agent on file for this company is secretary of state and is located at 2 south salisbury street, raleigh, nc 27601. The companys filing status is listed as good standing and its file number is f806630. Abraxane is the first albuminbound taxane particle of approximately nanometers that takes. Explore the abraxis bioscience, llc business page in bridgewater, nj. The deal was seen as an opportunity for celgene to.
Abraxis s portfolio included the worlds first proteinbased nanoparticle chemotherapeutic compound, called nab technology. Manta has 26 companies under pharmaceuticals in summit, new jersey. Abraxis had appealed against the refusal by the uk intellectual property office uk ipo to grant an spc covering abraxis nabpaclitaxel product, abraxane. Summit, new jerseybased celgene, which last week agreed to be. In november 2011, celgene relocated its united kingdom headquarters from windsor, berkshire. Jobs confirms plan to spinoff abraxis health in 2010. Abraxis bioscience launches abraxane in germany business. Jun 30, 2010 in addition, investors and stockholders may obtain free copies of the documents filed with the sec by directing a written request to. The transaction adds abraxane nanoparticle albuminbound paclitaxel to the companys existing portfolio of leading cancer products and offers another significant scientific platform that may drive. Patents assigned to abraxis bioscience, llc justia patents. Celg today announced it has completed its acquisition of abraxis bioscience, inc. August 08, 2019 new jersey abraxis bioscience, llc v.
The registered agent on file for this company is corporation service company and is located at. Summit, nj patch breaking local news events schools weather. The company has a critical mass of people with years of relevant experience and. Abraxis bioscience, llc is a north dakota foreign limitedliability company filed on november 17, 2009. Summit is the only cdmo exclusively focused on helping pharmaceutical industry clients bring intranasal medicines to market.
The companys filing status is listed as currentactive and its file number is 1015780. A corporate filing is called a foreign filing when an existing corporate entity files in a state other than the state they originally filed in. Abraxis bioscience is a fully integrated biotechnology company dedicated to delivering progressive therapeutics, such as abraxane, and core technologies that. Recommended dosage of abraxane is 100 mgm 2 intravenously over 30 minutes on days 1, 8, and 15 of each 21day cycle. Jan 28, 2010 abraxis bioscience confirms plan to spinoff abraxis health in 2010 and announces management structure. Abraxis bioscience was a global biopharmaceutical company that developed treatments for critically ill patients. Cruce davila manufacturing facility in barceloneta, puerto rico.
Get breaking news and analysis on abraxis bioscience, inc. Gb09046 for a product described as paclitaxel formulated as albumin bound nanoparticles the application on the ground that it did not comply with. Acquired by celgene corporation ex abraxis bioscience, inc. Sta celgene acquires abraxis bioscience and leading anti. Abraxis bioscience launches abraxane in germany abraxane now available in germany and the united kingdom with additional eu countries to follow in 2009 february 04, 2009 12. Abraxis bioscience is a fully integrated biotechnology company dedicated to delivering progressive therapeutics. Lease agreement between app pharmaceuticals, llc and abraxis bioscience, llc for the warehouse facilities located at 2045 n. Abraxis bioscience buys manufacturing complex from pfizer. With an eye to burnishing its oncology rep and its already sizable revenue, celgene has struck a deal to buy abraxis bioscience for cash and.
Abraxis bioscience, inc 86 morris avenue summit, nj 07901 908 6739000. Celgene summit, new jersey completes acquisition of abraxis bioscience, inc. Celgene corporation summit, nj 07901 abraxane is a registered. In the legal profession, information is the key to success. Abraxis bioscience is a fully integrated biotechnology company dedicated to delivering progressive therapeutics, such as abraxane, and core technologies that offer patients and medical. Acquired by celgene corporation exabraxis bioscience, inc. Abraxis bioscience launches abraxane in germany fiercebiotech. Abraxis bioscience launches abraxane in germany business wire. Desai prion free nanoparticle compositions and methods of making thereof. Centerview partners llc is acting as financial advisor to receptos. Abraxane paclitaxel injection, powder, lyophilized, for.
Celgene rsrch and inv co llc 86 morris avenue summit, nj 07901 908 6739540. This corporate entity was filed approximately nineteen years ago on monday, october 22, 2001, according to public records filed with california secretary of state. Abraxis bioscience, llc is a new jersey foreign limitedliability company filed on december 1, 2007. Abraxis bioscience plans to separate into two companies. From the discovery and research phase to development and commercialization. Recommended dosage of abraxane is 125 mgm 2 intravenously over 3040 minutes on. The registered agent on file for this company is corporation service company and is located at 327 hillsborough street, raleigh, nc 276031725. Abraxis bioscience confirms plan to spinoff abraxis health in 2010 and announces management structure. Abraxis bioscience is a fully integrated global biotechnology company dedicated to the discovery, development and delivery of nextgeneration therapeutics and core technologies that offer patients. Learn how celgene, a global biopharmaceutical company, is committed to improving the lives of patients worldwide by delivering truly innovative and. Abraxis bioscience, llc in bismarck, nd company info. Patents assigned to abraxis bioscience, llc justia. Learn how celgene, a global biopharmaceutical company, is committed to improving the lives of patients worldwide by delivering truly innovative and lifechanging treatments.
Company profile page for abraxis bioscience llc including stock price, company news, press releases, executives, board members, and contact information. Abraxis bioscience, llc filed as a foreign in the state of california on wednesday, december 5, 2007 and is approximately thirteen years old, as recorded in documents filed with california secretary of state. It is important to note that this is a foreign filing. Search or browse our list of pharmaceuticals companies in summit, new jersey by category.
From this the company developed abraxane, a treatment for. In june 2010, celgene agreed to acquire abraxis bioscience. Filing 179 opinion filed re 7 motion for joinder pursuant to federal rule 25 filed by abraxis bioscience, inc. The west side of phoenix is now home to one of the most sophisticated nanobiologics manufacturers in the world. This is an appeal by the appellant abraxis against the decision of dr jim houlihan, deputy director, acting for the comptrollergeneral of patents, dated 26 august 2016 o41016 to refuse abraxis spc application no. Judgment of the court fourth chamber of 21 march 2019.
645 435 593 945 906 1530 691 1116 162 1345 1063 1419 1509 946 1038 1150 155 879 1375 726 314 22 1478 238 1041 199 1338 1651 1129 532 330 1332 1132 173 1465 1531 1417 980 1137 521 525 870 180 1488 319 701